TU-8 Increase comprehensive Medicaid insurance coverage of evidence-based treatment for nicotine dependency in States and the District of Columbia

National Data Source
State Medicaid Coverage for Tobacco-Dependence Treatments; Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health and University of California, Berkeley, Center for Health and Public Policy Studies (CDC/NCCPHP/OSH and Berkeley, CHPPS)
Changed Since the Healthy People 2020 Launch
No
Measure
number 
Baseline (Year)
6 (2007)
Target
51
Target-Setting Method
Total coverage
Numerator
Number of States and the District of Columbia that provide the recommended full coverage of all tobacco-dependence treatments (FDA-approved medications and counseling) to help smokers quit.
Data Collection Frequency
Periodic
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective

Comments

Methodology Notes

The recommended full coverage of all tobacco-dependence treatments (FDA-approved medications and counseling) is defined as coverage of all of the following: • Medication coverage: Gum, Patch, Nasal spray, Inhaler, Lozenge, Varenicline , Bupropion hydrochloride • Counseling coverage: Group, Individual, Telephone.

Changes Between HP2010 and HP2020
For HP2020 the data souce had been changed to the State Medicaid Coverage for Tobacco Survey, which is conducted by CDC's office on Smoking and Health.